NewsMarkets

Health

Promising Heart Drugs Fail to Prevent Attacks in Clinical Trials

Two experimental drugs heralded as a new era in heart disease treatment failed to prevent heart attacks, leaving cardiologists to investigate the causes.

2 publishers · 2 articles · first seen 10 Sept 2026 · updated 45d ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

This story has stopped developing; this page is its permanent record. More from that day

The story so far

2 publishers have covered this in 2 articles since 10 Sept 2026. STAT published first, on 10 September at 17:29 UTC; The New York Times followed 20h 25m later. The most recent article, from The New York Times, appeared on 11 September at 13:54 UTC.

Outlets reporting it: The New York Times (major outlet), STAT.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. A Promising Heart Drug Failed. What Went So Wrong? The New York Times ·
  2. Why two promising heart drugs flopped and what’s next STAT

In this story

  • New York Times
Embed this story

Paste this into any web page to show the live odds, with a link back here.